LM Advisors’s CVS Health CVS Stock Holding History

LM Advisors’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-1,942	Closed	-$153K	–	321
2023 Q4	$153K	Buy	+1,942	New	+$138K	0.03%	216

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LM Advisors's CVS Position: Q1 2024 in Review

LM Advisors sold out of CVS Health (CVS) in Q1 2024, closing a stake of 1,942 shares — an estimated $153K sold.

LM Advisors first reported a position in CVS in Q4 2023 and held it in 1 quarter. The position peaked at $153K in Q4 2023. 2,176 funds tracked by Wall St. Rank hold CVS as of Q1 2024.

LM Advisors reported no remaining CVS Health position as of Q1 2024 after selling out during the quarter.
LM Advisors sold 1,942 CVS Health shares in Q1 2024, an estimated $153K.
LM Advisors first reported a position in CVS Health in Q4 2023 and held it in 1 quarter.
LM Advisors's CVS Health position peaked at $153K in Q4 2023.
2,176 funds tracked by Wall St. Rank held CVS Health as of Q1 2024.

Based on LM Advisors's 13F filing for Q1 2024, filed 15 May 2024.